Tianjin Development's subsidiary subscribes to a financial product worth 50 million yuan
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Tianjin Development announced that on June 19, 2025, Lifeng Pharmaceutical (an indirectly non-wholly-owned subsidiary of the company) entered into the ninth wealth management agreement with Xingyin Wealth Management and Industrial Bank, subscribing to another fixed-income investment product with a principal amount of RMB 50 million
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments